These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6312064

  • 21. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
    Kostial K, Kargacin B, Blanusa M, Piasek M, Jones MM, Singh PK.
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
    [Abstract] [Full Text] [Related]

  • 22. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
    Kostial K, Blanusa M, Simonović I, Jones MM, Singh PK.
    J Appl Toxicol; 1993 Sep; 13(5):321-5. PubMed ID: 8258628
    [Abstract] [Full Text] [Related]

  • 23. gamma-Glutamyltransferase-dependent biliary-hepatic recycling of methyl mercury in the guinea pig.
    Dutczak WJ, Ballatori N.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):619-23. PubMed ID: 1354255
    [Abstract] [Full Text] [Related]

  • 24. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
    Maiorino RM, Akins JM, Blaha K, Carter DE, Aposhian HV.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
    [Abstract] [Full Text] [Related]

  • 25. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
    Kostial K, Blanusa M, Piasek M, Jones MM, Singh PK.
    Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
    [Abstract] [Full Text] [Related]

  • 26. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN, Prince RC, Gailer J, Buttigieg GA, Denton MB, Harris HH, Pickering IJ.
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. DMSA administration to patients with alleged mercury poisoning from dental amalgams: a placebo-controlled study.
    Sandborgh Englund G, Dahlqvist R, Lindelöf B, Söderman E, Jonzon B, Vesterberg O, Larsson KS.
    J Dent Res; 1994 Mar; 73(3):620-8. PubMed ID: 8163732
    [Abstract] [Full Text] [Related]

  • 31. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
    Juresa D, Blanusa M, Kostial K.
    Toxicol Lett; 2005 Jan 15; 155(1):97-102. PubMed ID: 15585364
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA).
    Roels HA, Boeckx M, Ceulemans E, Lauwerys RR.
    Br J Ind Med; 1991 Apr 15; 48(4):247-53. PubMed ID: 1851035
    [Abstract] [Full Text] [Related]

  • 36. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB, Anderson RL, Super DM.
    Pediatrics; 1995 Oct 15; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [Abstract] [Full Text] [Related]

  • 37. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
    Kostial K, Restek-Samarzija N, Blanusa M, Piasek M, Jones MM, Singh PK.
    Pharmacol Toxicol; 1997 Nov 15; 81(5):242-4. PubMed ID: 9396091
    [Abstract] [Full Text] [Related]

  • 38. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
    Fang X, Hua F, Fernando Q.
    Chem Res Toxicol; 1996 Nov 15; 9(1):284-90. PubMed ID: 8924605
    [Abstract] [Full Text] [Related]

  • 39. Urine mercury excretion following meso-dimercaptosuccinic acid challenge in fish eaters.
    Ruha AM, Curry SC, Gerkin RD, Caldwell KL, Osterloh JD, Wax PM.
    Arch Pathol Lab Med; 2009 Jan 15; 133(1):87-92. PubMed ID: 19123743
    [Abstract] [Full Text] [Related]

  • 40. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA.
    J Pharmacol Exp Ther; 1988 Jul 15; 246(1):84-91. PubMed ID: 2839672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.